Trading Signals: CGEN Stock Price Prediction and Forecast (Wed. Jun. 11, 2003 - Fri. May. 13, 2022)(Compugen Ltd.)
| CGEN latest price $6.6000 (-3.08%) ($6.5200 - $6.7400) on Mon. Sep. 26, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.16% (three month average) | RSI | 23 | Latest Price | $6.6000(-3.08%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CGEN declines -0.3% a day on average for past five trading days. | Weekly Trend | CGEN declines -2.9% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support CGEN advance at 0% a week (0% probability) EWG(4%) TBT(4%) URA(4%) BOTZ(3%) XRT(3%) | Factors Impacting CGEN price | CGEN will decline at least -1.08% in a week (0% probabilities). VCSH(-8%) VCIT(-8%) USO(-8%) TIP(-7%) BNDX(-7%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.08% (StdDev 2.16%) | Hourly BBV | 0 () | Intraday Trend | -1.9% | | | |
|
1 - 5 Day Possible Target | $0.81(-87.73%) | Resistance Level | $6.91 | 5 Day Moving Average | $6.71(-1.64%) | 10 Day Moving Average | $6.74(-2.08%) | 20 Day Moving Average | $6.91(-4.49%) | To recent high | -10.9% | To recent low | 2.8% | Market Cap | $546m | | | | Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. |